Page 1380 - Clinical Small Animal Internal Medicine
P. 1380

1318  Section 11  Oncologic Disease

            metastatic rate (up to 50%). Definitive diagnosis   Feline vaginal tumors are extremely rare, with most
  VetBooks.ir  requires histology and is easily obtained at the time of   being benign.
            hysterectomy.


            Therapy                                           Epidemiology
                                                              In dogs, there is some evidence that vaginal neoplasia
            Ovariohysterectomy is the treatment of choice in all   may be associated with a history of mammary tumors,
            cases of uterine tumors, except in the setting of distant   ovarian cysts, pyometra or previous treatment with
            metastasis or carcinomatosis. Surgical excision of any   reproductive hormones. One study found that the
            regional metastatic foci is also recommended.       majority of dogs with vaginal cancer are sexually intact
             In women, adjunctive chemotherapy has been shown   and nulliparous.
            to have a mild to modest benefit for metastatic leiomyo-
            sarcomas and carcinosarcomas when compared to sur-  Signalment
            gery or radiation alone. Although there are no veterinary
            reports on the use of chemotherapy for uterine tumors,   The mean age for dogs with vaginal cancer is 10.8 years.
            it  is highly recommended in cases of malignant or   Although there is no breed predilection, both boxers and
              metastatic  tumors.  Based  on  human data, it  would  be   poodles have been reported to have an increased risk.
            reasonable to consider chemotherapeutics such as cispl-
            atin, carboplatin, doxorubicin, cyclophosphamide, gem-  History and Clinical Signs
            citabine, and ifosfamide as viable therapeutic options.
             A 2007 study evaluated the presence of estrogen and   Common clinical signs reported include purulent to
            progresterone receptors in smooth muscle genital   hemorrhagic vaginal discharge, swelling of the vulva or
            tumors. Estrogen receptor alpha (ERalpha) was found in   perineal region, a vulvar mass, constant licking of the
            56.3% and progesterone receptor (PR) in 84.4% of canine   vulva, dysuria or tenesmus. Tumors typically arise from
            tumors. This finding makes hormone receptor antago-  the vulva, vestibule, or vaginal roof. There is no correla-
            nist therapy a reasonable treatment option.       tion between the location of the mass and histologic
                                                              tumor type.
            Prognosis
                                                              Diagnosis
            The prognosis is excellent for dogs and cats with benign
            tumors following complete ovariohysterectomy. For   Definitive diagnosis of malignancy requires histology.
            malignant tumors localized to the uterus, the prognosis   However, the presence of a vaginal mass is often easily
            can be good as many of these dogs can still be cured with   determined based on history, clinical signs, and physical
            surgery. However, the prognosis is guarded for meta-  exam findings (including a digital vaginal exam). For
            static tumors. In cats with uterine adenocarcinomas, the   small lesions, vaginoscopy may be required. Full staging
            prognosis is guarded to poor as they often metastasize.  is recommended for all  animals with vaginal tumors:
                                                              complete blood count, biochemistry, three‐view  thoracic
                                                              radiographs, and an abdominal ultrasound. Paraneoplastic
              Vaginal Tumors                                  hypercalcemia has been infrequently reported to be
                                                              associated with older basset hounds with clitoral
                                                              adenocarcinoma.
            Etiology/Pathophysiology
            Vaginal tumors are the second most common tumor of   Treatment
            the  female reproductive  system.  The most  common
              histologic type is leiomyoma. These tumors, similar to   Surgical excision with dorsal episiotomy is the treat-
            the uterine leiomyomas, are slow growing and do not   ment of choice. Concurrent ovariohysterectomy is also
            metastasize. Other less common tumors include fibroma,   recommended as some malignancies such as leiomyo-
            polyp, lipoma, myxoma, lymphoma, liposarcoma, mast   mas may be hormone dependent. For highly invasive
            cell tumor, adenocarcinoma, squamous cell carcinoma,   vaginal tumors, either subtotal vaginectomy or a com-
            fibrosarcoma,  leiomyosarcoma,  osteosarcoma,  heman-  plete   vulvovaginectomy and perineal urethrostomy
            giosarcoma, and TVT.                              can be performed. It is advised that any metastatic foci
             One  study  found  that  all  pedunculated  masses  were   should be removed at the same time.
            benign. And of the sessile, broad‐based masses, all were   Adjunctive radiation therapy and chemotherapy can
            malignant (with the majority being TVT).          be considered for animals that have incompletely excised
   1375   1376   1377   1378   1379   1380   1381   1382   1383   1384   1385